Are you Dr. Schmidt?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 19 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
10 Msc 1277
Bldg 10-CRC
Bethesda, MD 20892Phone+1 301-496-6120
Summary
- Dr. Peter Schmidt, MD is a psychiatrist in Bethesda, Maryland. He is currently licensed to practice medicine in Maryland and Virginia. He is a Chief of the Section on Behavioral Endocrinology (SBE) at National Institute of Mental Health..
Education & Training
- Royal College of Surgeons IrelandClass of 1982
Certifications & Licensure
- VA State Medical License 1989 - 2026
- MD State Medical License 1992 - 2025
Clinical Trials
- Study of Premenstrual Syndrome and Premenstrual Dysphoria Start of enrollment: 1984 Mar 09
- Perimenopause-Related Mood and Behavioral Disorders Start of enrollment: 1989 Mar 06
- A Treatment Study for Premenstrual Syndrome (PMS) Start of enrollment: 1992 Aug 11
- Join now to see all
Publications & Presentations
PubMed
- 243 citationsThe recommendations of a consensus panel for the screening, diagnosis, and treatment of neurogenic orthostatic hypotension and associated supine hypertensionChristopher H. Gibbons, Peter Schmidt, Italo Biaggioni, Camille Frazier-Mills, Roy Freeman
Journal of Neurology. 2017-01-03 - 65 citationsCerebrospinal Fluid and Behavioral Changes After Methyltestosterone Administration: Preliminary FindingsRobert C. Daly, Tung Ping Su, Peter Schmidt, David Pickar, Dennis L. Murphy
Archives of General Psychiatry. 2001-02-01 - 80 citationsA mutation in the gene for the neurotransmitter receptor-clustering protein gephyrin causes a novel form of molybdenum cofactor deficiency.Jochen Reiss, Sigrid Gross-Hardt, Ernst Christensen, Peter Schmidt, Ralf R. Mendel
American Journal of Human Genetics. 2001-01-01
Press Mentions
- Resting-State Functional Connectivity, Cortical GABA, and Neuroactive Steroids in Peripartum and Peripartum Depressed Women: A Functional Magnetic Resonance Imaging and Spectroscopy StudyOctober 17th, 2019
- Brexanolone Approval ‘Marks an Important Milestone’April 8th, 2019
- We Might FINALLY Know What Causes Extreme PMS (Called PMDD) — and You're Not Gonna like ItJanuary 11th, 2017
- Join now to see all
Grant Support
- Psychobiology And Treatment Of Peri-Menopausal Mood DisordersNational Institute Of Mental Health1996–1997
Professional Memberships
- Member